How should PET influence the management of lung cancer?

C. Dooms (Leuven, Belgium)

Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?
Session: ME11 How should PET influence the management of lung cancer?
Session type: Meet the expert
Number: 4556

PDF journal article, handout or slidesMultimedia files

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Dooms (Leuven, Belgium). How should PET influence the management of lung cancer?. Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Michele Gallo - 12.10.2013 19:03
Excellent contribution
You must Login to comment this presentation.


Related content which might interest you:
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



The role of PET/CT in lung cancer staging
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



PET/CT of lung cancer
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team
Source: Eur Respir J 2009; 33: 941-942
Year: 2009


Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018

Combining bronchoscopy and PET for assessment and staging of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 678s
Year: 2005

Impact of PET scanning on lung cancer management in a U.K. centre
Source: Eur Respir J 2006; 28: Suppl. 50, 83s
Year: 2006

Effectiveness of PET scan in postoperative long term follow up of patients with nonsmall cell lung cancer
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008

Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity?
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012